B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC

BACKGROUND: The combination of drug delivery with immune checkpoint targeting has been extensively studied in cancer therapy. However, the clinical benefit for patients from this strategy is still limited. B7 homolog 3 protein (B7-H3), also known as CD276 (B7-H3/CD276), is a promising therapeutic ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bing, Zheng, Kaifan, Fang, Shubin, Huang, Kangping, Chu, Chengchao, Zhuang, Junyang, Lin, Jin, Li, Shaoguang, Yao, Hong, Liu, Ailin, Liu, Gang, Lin, Jizhen, Lin, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583352/
https://www.ncbi.nlm.nih.gov/pubmed/37848956
http://dx.doi.org/10.1186/s12951-023-02078-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583352/
https://www.ncbi.nlm.nih.gov/pubmed/37848956
http://dx.doi.org/10.1186/s12951-023-02078-9

Ejemplares similares